Status:
COMPLETED
Association of COPD Maintenance Medication Adherence With Resource Use and Cost Among COPD Patients
Lead Sponsor:
AstraZeneca
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
Brief Summary
The aim of this study is to examine the association of COPD maintenance inhalation medication (Inhaled Corticosteroid or ICS) adherence with COPD exacerbation healthcare resource utilization among COP...
Detailed Description
Objectives: The primary objective of this study is to examine the association of COPD maintenance inhalation medication (Inhaled Corticosteroid or ICS) adherence with COPD exacerbation healthcare reso...
Eligibility Criteria
Inclusion
- Patients diagnosed with COPD in 2015;
- Patients had complete hospital visit data available during pre-index 1 year period and post 1 year follow-up;
- Patients had at least one COPD exacerbation during 1 year prior to the index date;
- Patients had at least 2 COPD maintenance medication claims during post index 1 year period, as 2 claims are recommended to calculate adherence.
Exclusion
- Inability to determine diagnoses from claims;
- Individuals with other chronic respiratory conditions such as respiratory cancer, pulmonary fibrosis, asthma.
Key Trial Info
Start Date :
June 7 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 20 2018
Estimated Enrollment :
10067 Patients enrolled
Trial Details
Trial ID
NCT03359122
Start Date
June 7 2018
End Date
August 20 2018
Last Update
July 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research site
Beijing, China, 100000